|
About the Nitrosamines in the News category
|
|
0
|
504
|
April 14, 2021
|
|
⛑️ Need your help to do user acceptance testing of the new Nitrosamine Exchange home!
|
|
7
|
133
|
October 12, 2026
|
|
Another Prazosin recall linked to N-nitroso-prazosin impurity C raises renewed concern for the finished product
|
|
10
|
944
|
July 7, 2026
|
|
N-NO formation in 2-mercaptobenzothiazole
|
|
2
|
162
|
April 29, 2026
|
|
Potential for Nitrosamines in Medical Device Combination Products - Letter to Industry(FDA)
|
|
4
|
265
|
April 20, 2026
|
|
EMA proposes GMP update to EudraLex to address nitrosamine impurities
|
|
14
|
1349
|
February 20, 2026
|
|
Determination That ZANTAC (Ranitidine Hydrochloride) Injection, Equivalent to 25 Milligrams Base/Milliliter, Has Not Been Withdrawn From Sale for Reasons of Safety or Effectiveness
|
|
1
|
310
|
December 17, 2025
|
|
WHO Updates on Nitrosamine Impurities
|
|
3
|
815
|
December 3, 2025
|
|
I found a recent review paper on nitrsoamine risk assessment in pharmaceuticals
|
|
6
|
801
|
December 3, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
664
|
November 27, 2025
|
|
𝗡-𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 𝗙𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗗𝗿𝘂𝗴 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀: 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗮 𝗕𝗶𝗮𝘀𝗲𝗱, 𝗖𝗼𝗻𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝘃𝗲, 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗠𝗼𝗱𝗲𝗹
|
|
1
|
383
|
November 26, 2025
|
|
FDA is serious about risk assessments!
|
|
3
|
733
|
November 11, 2025
|
|
FDA recalls blood pressure medicine over cancerous chemical
|
|
2
|
752
|
November 5, 2025
|
|
US FDA- Generic Drug Science and Research Priority Initiatives for Fiscal Year (FY) 2024
|
|
2
|
648
|
October 1, 2025
|
|
Nostertamine Nitrosamine
|
|
0
|
132
|
August 19, 2025
|
|
"Ribolaris" clinical trial has been partially suspended due to nitrosamine impurities in ribociclib batches
|
|
2
|
649
|
June 24, 2025
|
|
FDA Accelerating the use of AI-Assisted Scientific Review
|
|
3
|
455
|
May 12, 2025
|
|
Total Nitrosamine Analyzer
|
|
3
|
474
|
May 12, 2025
|
|
Health Canada: Nitrosamine impurities Update July 26, 2024
|
|
16
|
2067
|
May 9, 2025
|
|
Novartis pauses some trials of cancer drug Kisqali to fix manufacturing
|
|
15
|
3206
|
April 25, 2025
|
|
🕵🏻 OTC Market Withdrawal of Diphenhydramine
|
|
0
|
778
|
April 24, 2025
|
|
Health Canada recalled drug products
|
|
0
|
830
|
April 1, 2025
|
|
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
|
|
0
|
262
|
March 28, 2025
|
|
Phathom Pharmaceuticals reported nitrosamine impurity in their vonoprazan-based products
|
|
25
|
3970
|
March 20, 2025
|
|
Recent Updates in the Regulation of Nitrosamine Impurities
|
|
0
|
481
|
February 27, 2025
|
|
Controversial but Public Report
|
|
0
|
804
|
November 6, 2023
|
|
FDA Updates Recall on Blood Pressure Medication Due to Possible Carcinogen
|
|
3
|
1220
|
December 27, 2024
|
|
Varenicline back available in the UK
|
|
0
|
195
|
November 12, 2024
|
|
Cinacalcet Recall
|
|
3
|
956
|
November 4, 2024
|
|
4000 Members Milestone 🎉
|
|
21
|
1170
|
October 24, 2024
|